Clinical Trials Logo

Preterm Infants clinical trials

View clinical trials related to Preterm Infants.

Filter by:

NCT ID: NCT02103777 Completed - Apnea Clinical Trials

High Versus Low Dose of Caffeine for Apnea of Prematurity

Start date: September 2011
Phase: Phase 3
Study type: Interventional

The optimum caffeine dose for apnea of prematurity has not been well investigated so the objective of the study is to compare high versus low dose of caffeine citrate to facilitate successful extubation in mechanically ventilated preterm infants.

NCT ID: NCT02066610 Completed - Preterm Infants Clinical Trials

Effect of Selenium Supplementation on Trace Mineral Antioxidant Enzyme and Amino Acid Metabolism in Infants

Start date: March 1991
Phase: N/A
Study type: Interventional

The objectives of the study were to assess the serum selenium, zinc, and copper status and plasma and white blood cell antioxidant enzyme activities of low birth weight infants receiving selenium supplemented and non-selenium supplemented parenteral nutrition from initiation of parenteral nutrition until discontinuation of preterm formula or hospital discharge.

NCT ID: NCT01996670 Completed - Clinical trials for Bronchopulmonary Dysplasia

Early NCPAP Before Surfactant Treatment in Very Preterm Infants With RDS

Start date: January 2007
Phase: N/A
Study type: Observational

We hypothesis a period of early NCPAP before surfactant treatment is effective for treating RDS and preventing BPD in very premature infants.

NCT ID: NCT01841268 Completed - Preterm Infants Clinical Trials

Skin Lipid Profiles in Term and Preterm Infants

Start date: May 2010
Phase:
Study type: Observational [Patient Registry]

This study is designed to compare the skin lipid and protein composition between term and premature infants and determine how the skin composition changes over the first four weeks of life. The investigators hope to elucidate the unique characteristics of premature skin by measuring the lipid and protein content in skin, how it changes during the first month of life, and how it varies with formula feeding versus breast feeding. Additionally, the investigators will study the relationships among diet, skin composition and plasma lipids in premature infants over the first four weeks of life.

NCT ID: NCT01813682 Recruiting - Preterm Infants Clinical Trials

Effect of Iron-fortified TPN on Preterm Infants Anemia

Start date: September 2012
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether iron-fortified TPN is effective in the preventative and treatment of preterm infants. Preterm infants are at risk for anemia especially in preterm infants. Generally the smaller Birth weight and gestational age the higher anemia rate in infants. About 25% to 85% of preterm infants develop evidence of anemia during infancy,77% VLBW(very low birth weight) infants developed anemia during the hospital stay. The effects of iron deficiency are pervasive and involve multiple organ systems. Poor physical growth, gastrointestinal disturbances, thyroid dysfunction, altered immunity and temperature instability has been attributed to iron deficiency in very low birth weight infants. So it is important to provide iron for preterm infants. As enteral nutrition is not feasible soon after birth in most preterm infants, Parenteral iron administration is an efficacious method for us to select. For most preterm infants the use of TPN(total parenteral nutrition) is very common during the first ten days of life, so we hypothesis that iron-fortified TPN may have a preventative and treatment effect on preterm infants using TPN as a supplementation of oral nutrition; Iron-fortified TPN(total parenteral nutrition) can also improve iron store status of preterm infants. The higher concentration of iron used in this study the larger preventative or treatment effect on preterm infants anemia; It is safe to add Small dose of iron agent to TPN.

NCT ID: NCT01786759 Recruiting - Preterm Infants Clinical Trials

Hepatic Function and Bile Acid in Preterm Infants Receiving Parenteral Lipids Emulsion

Start date: October 2012
Phase: Phase 4
Study type: Interventional

The etiology of parenteral nutrition-associated cholestasis(PNAC)although elusive is thought to be multifactorial, and proposed theories also include problems arising from lipid emulsions, leading us to explore alternative products available elsewhere.So we compare the different fat emulsion, and want to see if the olive oil lipid emulsions can improve hepatic tolerance in preterm infant.

NCT ID: NCT01778101 Completed - Preterm Infants Clinical Trials

Lansoprazole in Preterm Infants With Reflux

Start date: January 2013
Phase: Phase 2
Study type: Interventional

This study is pilot study to evaluate safety and efficacy of lansoprazole in preterm infants with gastroesophageal reflux documented by 24hr pH impedance monitoring

NCT ID: NCT01713127 Terminated - Preterm Infants Clinical Trials

Remifentanil in Ventilated Preterm Infants

Start date: August 2012
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this study is to evaluate efficacy of remifentanil in preterm infants during ventilator care with remifentanil and to analyze pharmacokinetics in preterm infants

NCT ID: NCT01615523 Not yet recruiting - Preterm Infants Clinical Trials

Executive Function in Preterm Born Children: An Integrative Approach From Genetics to Brain Function

Start date: September 2012
Phase: N/A
Study type: Observational

Hd-EEG and MRI measures are used to study the maturation of functional networks in order to identify the neural circuits underlying executive and memory processes in children born preterm. It will be determined whether children born preterm with executive function deficits will have an abnormal connectivity between basal ganglia and cortex due to WM injury. Moreover, the development of hd-EEG activity during sleep (coherence and travelling waves) and brain maturation of children and adolescents born preterm will be compared with the respective measures in healthy controls. This is of eminent importance as it helps to understand the nature of executive function and hence, it may help to develop neuroprotective strategies to prevent executive function deficits in these infants.

NCT ID: NCT01600430 Completed - Clinical trials for Vitamin D Deficiency

Vitamin D Supplementation for Extremely Preterm Infants

Start date: June 2012
Phase: Phase 2/Phase 3
Study type: Interventional

The study hypothesis states that giving early enteral Vitamin D supplementation to preterm infants will decrease respiratory morbidity in extremely preterm infants.